Discontinuing obesity medicines often means the weight comes back and people lose the cardiovascular and metabolic benefits ...
An extension study of Amgen's experimental obesity drug MariTide found that it helped people maintain weight loss while ​a ...
Eli Lilly said on Thursday a late-stage trial showed its weight-loss drug Zepbound, used with its psoriatic arthritis ...
A new study finds that people who quit weight-loss medications, including GLP-1 drugs, regain weight four times faster than ...
People who took both Zepbound and an anti-inflammatory drug saw a greater improvement of their psoriatic arthritis symptoms.
For some, these medications have led to profound weight loss and often improvements in heart health. Research published on ...
People taking weight-loss drugs are likely to regain the weight they have lost within two years of stopping the medications, ...
Millions of Americans are using GLP-1s. But so far, there has been comparatively less research on what happens when users ...
Bariatric surgery far outperformed GLP-1 weight loss drugs in a new real-world comparison of more than 50,000 patients. Two ...
The cost, the shortages, and even the side effects have led to older people who start Ozempic, Wegovy, and similar drugs to ...
Eli Lilly said combining Taltz and Zepbound improved arthritis symptoms and drove meaningful weight loss, outperforming Taltz ...
If you are considering both Ozempic and Zepbound for weight loss, it can be helpful to compare the two side by side before ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results